Hauke Walter

Hauke Walter

UNVERIFIED PROFILE

Are you Hauke Walter?   Register this Author

Register author
Hauke Walter

Hauke Walter

Publications by authors named "Hauke Walter"

Are you Hauke Walter?   Register this Author

44Publications

923Reads

46Profile Views

Using drug exposure for predicting drug resistance - A data-driven genotypic interpretation tool.

PLoS One 2017 10;12(4):e0174992. Epub 2017 Apr 10.

Department of Computational Biology and Applied Algorithmics, Max-Planck-Institut für Informatik, Saarbrücken, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0174992PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386274PMC
August 2017

Results of the first international HIV-1 coreceptor proficiency panel test.

J Clin Virol 2017 08 10;93:53-56. Epub 2017 Jun 10.

Institute of Virology, University of Cologne, 50935 Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2017.06.002DOI Listing
August 2017

Geno2pheno[HCV] - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents.

PLoS One 2016 19;11(5):e0155869. Epub 2016 May 19.

German Center for Infection Research (DZIF)-Saarbrücken Partner Site, Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, 66123, Saarbrücken, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155869PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873220PMC
July 2017

HIV-1 persistent viremia is frequently followed by episodes of low-level viremia.

Med Microbiol Immunol 2017 Jun 20;206(3):203-215. Epub 2017 Feb 20.

Clinic of Dermatology, University Hospital, University of Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00430-017-0494-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409919PMC
June 2017

Determination of Phenotypic Resistance Cutoffs From Routine Clinical Data.

J Acquir Immune Defic Syndr 2017 04;74(5):e129-e137

*Department of Computational Biology and Applied Algorithmics, Max-Planck-Institut für Informatik, Saarbrücken, Germany; †Medizinisches Infektiologiezentrum Berlin, Berlin, Germany; ‡Medizinisches Labor Stendal, Stendal, Germany; §Institute for Virology, University Clinic of Cologne, Germany; ‖Institute of Virology, University of Düsseldorf, Germany; and ¶Clinic of Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351752PMC
April 2017

Development of a phenotypic susceptibility assay for HIV-1 integrase inhibitors.

J Virol Methods 2016 12 11;238:29-37. Epub 2016 Oct 11.

Institute of Virology, University of Cologne, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jviromet.2016.10.002DOI Listing
December 2016

Improved therapy-success prediction with GSS estimated from clinical HIV-1 sequences.

J Int AIDS Soc 2014 2;17(4 Suppl 3):19743. Epub 2014 Nov 2.

Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, Saarbrücken, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225326PMC
http://dx.doi.org/10.7448/IAS.17.4.19743DOI Listing
January 2016

New dolutegravir resistance pattern identified in a patient failing antiretroviral therapy.

J Int AIDS Soc 2014 2;17(4 Suppl 3):19749. Epub 2014 Nov 2.

Laboratory Berg, MIB - Medical Infectiology Center Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225390PMC
http://dx.doi.org/10.7448/IAS.17.4.19749DOI Listing
January 2016

Resistance remains a problem in treatment failure.

J Int AIDS Soc 2014 2;17(4 Suppl 3):19756. Epub 2014 Nov 2.

Outpatients Clinic, Medical Center for Infectious Diseases, Berlin, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225374PMC
http://dx.doi.org/10.7448/IAS.17.4.19756DOI Listing
January 2016

Association between HIV-1 coreceptor usage and resistance to broadly neutralizing antibodies.

J Acquir Immune Defic Syndr 2014 Oct;67(2):107-12

*Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, Saarbrücken, Germany; and †MVZ Medizinisches Infektiologiezentrum Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175123PMC
October 2014

Does "thinking about thinking" interfere with memory? An experimental memory study in obsessive-compulsive disorder.

J Anxiety Disord 2014 Oct 21;28(7):679-86. Epub 2014 Jul 21.

Department of Clinical Psychology and Psychotherapy, University of Leipzig, Neumarkt 9-19, D-04081 Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.janxdis.2014.07.009DOI Listing
October 2014

Targets for inhibition of HIV replication: entry, enzyme action, release and maturation.

Intervirology 2012 24;55(2):84-97. Epub 2012 Jan 24.

Institute of Virology, University of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000331995DOI Listing
May 2012

The SnoB study: frequency of baseline raltegravir resistance mutations prevalence in different non-B subtypes.

Med Microbiol Immunol 2011 Nov 8;200(4):225-32. Epub 2011 Apr 8.

Institute of Virology, University of Cologne, Fürst-Pückler-Str. 56, 50935 Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00430-011-0194-1DOI Listing
November 2011

Influence of major HIV-1 protease inhibitor resistance mutations on CTL recognition.

J Acquir Immune Defic Syndr 2011 Feb;56(2):109-17

Department of Internal Medicine 3, Institute of Clinical Immunology, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e3181fe946eDOI Listing
February 2011

The antiretroviral potency of emtricitabine is approximately 3-fold higher compared to lamivudine in dual human immunodeficiency virus type 1 infection/competition experiments in vitro.

Antiviral Res 2010 Jun 17;86(3):312-5. Epub 2010 Mar 17.

University of Erlangen-Nuremberg, Institute of Clinical and Molecular Virology, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.antiviral.2010.03.006DOI Listing
June 2010

Predicting therapy outcome in patients with early and late obsessive-compulsive disorder (EOCD and LOCD).

Behav Cogn Psychother 2009 Oct;37(5):485-96

Ludwig-Maximilians-Universität, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1352465809990294DOI Listing
October 2009

Determination of HIV-1 coreceptor tropism in clinical practise.

Eur J Med Res 2007 Oct;12(9):473-82

National Reference Center for Human Retroviruses, Institute for Clinical and Molecular Virology at the University of Erlangen-Nuremberg, Germany.

View Article

Download full-text PDF

Source
October 2007

Superiority of infectivity-based over particle-based methods for quantitation of drug resistant HIV-1 as inocula for cell cultures.

J Virol Methods 2007 Apr 28;141(1):87-96. Epub 2006 Dec 28.

Institute of Clinical and Molecular Virology, University of Erlangen-Nuremberg, Schlossgarten 4, D-91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jviromet.2006.11.040DOI Listing
April 2007

Persistence of lamivudine-sensitive HIV-1 quasispecies in the presence of lamivudine in vitro and in vivo.

J Acquir Immune Defic Syndr 2007 Apr;44(4):377-85

Institute of Clinical and Moleculr Virology, University of Erlangen-Nuremburg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e31803104c0DOI Listing
April 2007

Antiviral activity of Arthrospira-derived spirulan-like substances.

Antiviral Res 2006 Dec 30;72(3):197-206. Epub 2006 Jun 30.

Institute for Clinical and Molecular Virology, University of Erlangen-Nürnberg, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016635420600190
Publisher Site
http://dx.doi.org/10.1016/j.antiviral.2006.06.004DOI Listing
December 2006

Symptom-specific EEG power correlations in patients with obsessive-compulsive disorder.

Int J Psychophysiol 2006 Oct 22;62(1):87-92. Epub 2006 Mar 22.

Department of Psychiatry, Division of Clinical Neurophysiology, Ludwig-Maximilians-University of Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpsycho.2006.02.002DOI Listing
October 2006

Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.

AIDS 2005 Nov;19(16):1819-25

University of Erlangen-Nuremberg, Institute of Clinical and Molecular Virology, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.aids.0000189878.97480.edDOI Listing
November 2005

Implicit sequence learning in obsessive-compulsive disorder: further support for the fronto-striatal dysfunction model.

Biol Psychiatry 2005 Aug;58(3):239-44

Humboldt University at Berlin, Rudower Chaussee 18, D-12489 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopsych.2005.03.045DOI Listing
August 2005

Methods for optimizing antiviral combination therapies.

Bioinformatics 2003 ;19 Suppl 1:i16-25

Max Planck Institute for Informatics, Stuhlsatzenhausweg 85, 66123 Saarbrücken, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btg1001DOI Listing
October 2004

Tenofovir resistance and resensitization.

Antimicrob Agents Chemother 2003 Nov;47(11):3478-84

Institute of Clinical and Molecular Virology, German National Reference Centre for Retroviruses, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC253768PMC
http://dx.doi.org/10.1128/aac.47.11.3478-3484.2003DOI Listing
November 2003

Quality control trial for human immunodeficiency virus type 1 drug resistance testing using clinical samples reveals problems with detecting minority species and interpretation of test results.

J Clin Microbiol 2003 Aug;41(8):3559-65

Institute of Clinical and Molecular Virology, German National Reference Centre for Retroviruses, University of Erlangen-Nürnberg, D-91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC179843PMC
http://dx.doi.org/10.1128/jcm.41.8.3559-3565.2003DOI Listing
August 2003

Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes.

Nucleic Acids Res 2003 Jul;31(13):3850-5

Max Planck Institute for Informatics, Stuhlsatzenhausweg 85, D-66115 Saarbrücken, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC168981PMC
http://dx.doi.org/10.1093/nar/gkg575DOI Listing
July 2003

Distinct cross-resistance profiles of the new protease inhibitors amprenavir, lopinavir, and atazanavir in a panel of clinical samples.

AIDS 2003 May;17(8):1258-61

Institute of Clinicaland Molecular Virology, German National Reference Centre for Retroviruses, University of Erlangen-Nuremburg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00002030-200305230-00021DOI Listing
May 2003

P300 subcomponents in obsessive-compulsive disorder.

J Psychiatr Res 2002 Nov-Dec;36(6):399-406

Department of Psychiatry, Section of Clinical Neurophysiology and Outpatient Clinic for Obsessive-Compulsive Disorder, Ludwig-Maximilians University Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0022-3956(02)00055-9DOI Listing
March 2003

Genotypic drug resistance interpretation systems--the cutting edge of antiretroviral therapy.

AIDS Rev 2002 Jul-Sep;4(3):148-56

Institute of Clinical and Molecular Virology, National Reference Centre for Retroviruses, University of Erlangen-Nürnberg, Schlossgarten 4, D-91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
January 2003

No evidence for persistence of multidrug-resistant viral strains after a 7-month treatment interruption in an HIV-1-infected individual.

J Acquir Immune Defic Syndr 2002 Oct;31(2):137-46

Institute of Clinical and Molecular Virology, German National Reference Centre for Retroviruses, University of Erlangen-Nürnberg.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00126334-200210010-00003DOI Listing
October 2002

Technologies for measuring HIV-1 drug resistance.

HIV Clin Trials 2002 May-Jun;3(3):227-36

Institute of Clinical and Molecular Virology, German National Reference Centre for Retroviruses, University of Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1310/76w8-k4k7-m4kw-w57kDOI Listing
September 2002

Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype.

Proc Natl Acad Sci U S A 2002 Jun;99(12):8271-6

GMD-German National Research Center for Information Technology, Institute for Algorithms and Scientific Computing, Schloss Birlinghoven, D-53754 Sankt Augustin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.112177799DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC123057PMC
June 2002

Prediction of abacavir resistance from genotypic data: impact of zidovudine and lamivudine resistance in vitro and in vivo.

Antimicrob Agents Chemother 2002 Jan;46(1):89-94

Institute of Clinical and Molecular Virology, German National Reference Centre for Retroviruses, University of Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC126991PMC
http://dx.doi.org/10.1128/aac.46.1.89-94.2002DOI Listing
January 2002